LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Lymphoma Screen 18 Tissue Microarray - LS-SLYCA18

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SLYCA18
Product Name: Lymphoma Screen 18
Description: Hodgkin's lymphoma
Format: FFPE
Category: Human Tumor
QA/QC: H&E reviewed; IHC validated with a positive control antibody
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: No
Core Diameter: 1.5 mm
Core Thickness: 5 µm
Cases: 45
Cores: 80
Slides Per Set: 1

LS-SLYCA18 Tissue Microarray Map

Slide Number 1
LABEL
 12345678910
AMedMedLngLngLymLymLymLymSplSpl
BLymLymLymLymLymLymLymLymLymLym
CLymLymLymLymLymLymLymLymLymLym
DLymLymLymLymLymLymTngTngLymLym
ELymLymLymLymLymLymLymLymLymLym
FLymLymLymLymLymLymLymLymLymLym
GLymLymRetRetColColColColBstBst
HLymLymLymLymLymLymLymLymLymPla
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Breast (Bst); Colon (Col); Lung (Lng); Lymph node (Lym); Lymph node, Fibrofatty tissue (Lym); Mediastinum (Med); Placenta (Pla); Retroperitoneum (Ret); Spleen (Spl); Tongue (Tng);

LS-SLYCA18 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis Type
1A1HumanF37 yMediastinum (Med)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1A2HumanF37 yMediastinum (Med)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1A3HumanF22 yLung (Lng)Inflammation, ChronicInflammatory
1A4HumanF22 yLung (Lng)Hodgkin's lymphomaMalignant
1A5HumanM18 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1A6HumanM18 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1A7HumanM17 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1A8HumanM17 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1A9HumanM47 ySpleen (Spl)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1A10HumanM47 ySpleen (Spl)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1B1HumanF8 yLymph node (Lym)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1B2HumanF8 yLymph node (Lym)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1B3HumanF31 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1B4HumanF31 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1B5HumanM32 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1B6HumanM32 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1B7HumanM27 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1B8HumanM27 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1B9HumanF42 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1B10HumanF42 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1C1HumanF48 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1C2HumanF48 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1C3HumanM26 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1C4HumanM26 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1C5HumanM68 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1C6HumanM68 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1C7HumanM18 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1C8HumanM18 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1C9HumanM50 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1C10HumanM50 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1D1HumanM41 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1D2HumanM41 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1D3HumanM37 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1D4HumanM37 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1D5HumanM30 yLymph node (Lym)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1D6HumanM30 yLymph node (Lym)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1D7HumanM51 yTongue (Tng)Hodgkin's lymphoma, MixedMalignant
1D8HumanM51 yTongue (Tng)Hodgkin's lymphoma, MixedMalignant
1D9HumanM25 yLymph node (Lym)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1D10HumanM25 yLymph node (Lym)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1E1HumanM35 yLymph node (Lym)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1E2HumanM35 yLymph node (Lym)Hodgkin's lymphoma, Lymphocyte depletion typeMalignant
1E3HumanM27 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1E4HumanM27 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1E5HumanF37 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1E6HumanF37 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1E7HumanM34 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1E8HumanM34 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1E9HumanF33 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1E10HumanF33 yLymph node (Lym)Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)Malignant
1F1HumanM24 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1F2HumanM24 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1F3HumanM3 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1F4HumanM3 yLymph node (Lym)Hodgkin's lymphoma, MixedMalignant
1F5HumanM52 yLymph node (Lym)Lymphoma, Large B-cellMalignant
1F6HumanM52 yLymph node (Lym)Lymphoma, Large B-cellMalignant
1F7HumanF62 yLymph node (Lym)Lymphoma, Large B-cellMalignant
1F8HumanF62 yLymph node (Lym)Lymphoma, Large B-cellMalignant
1F9HumanM39 yLymph node (Lym)Lymphoma, Large B-cellMalignant
1F10HumanM39 yLymph node (Lym)Lymphoma, Large B-cellMalignant
1G1HumanF40 yLymph node (Lym)Lymphoma, Large B-cellMalignant
1G2HumanF40 yLymph node (Lym)Lymphoma, Large B-cellMalignant
1G3HumanM51 yRetroperitoneum (Ret)B-large non-cleaved cell lymphomaMalignant
1G4HumanM51 yRetroperitoneum (Ret)B-large non-cleaved cell lymphomaMalignant
1G5HumanF44 yColon (Col)B-small cleaved cell lymphomaMalignant
1G6HumanF44 yColon (Col)B-small cleaved cell lymphomaMalignant
1G7HumanM76 yColon (Col)B-small cleaved cell lymphomaMalignant
1G8HumanM76 yColon (Col)B-small cleaved cell lymphomaMalignant
1G9HumanF38 yBreast (Bst)B-small cleaved cell lymphomaMalignant
1G10HumanF38 yBreast (Bst)B-small cleaved cell lymphomaMalignant
1H1HumanM68 yLymph node (Lym)NormalBenign non-neoplastic
1H2HumanF42 yLymph node (Lym)NormalBenign non-neoplastic
1H3HumanF35 yLymph node (Lym)Sinus histocytosisDiseased
1H4HumanM69 yLymph node (Lym)Sinus histocytosisDiseased
1H5HumanF57 yLymph node, Fibrofatty tissue (Lym)NormalBenign non-neoplastic
1H6HumanM68 yLymph node (Lym)NormalBenign non-neoplastic
1H7HumanM61 yLymph node (Lym)NormalBenign non-neoplastic
1H8HumanM49 yLymph node (Lym)NormalBenign non-neoplastic
1H9HumanM62 yLymph node (Lym)NormalBenign non-neoplastic
1H10HumanF26 yPlacenta (Pla)NormalBenign non-neoplastic
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved